Watch the entire Ovarian Cancer Heroes program right here!
Related Content:
Zongertinib Elicits Responses in HER2-Mutant NSCLC
How an Advocate Unites Voices to Guide MPN Research Decisions
Healer, Mentor and Leader
Treatment With HT-KIT Shows Early Preclinical Activity in GIST Models
